BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24488880)

  • 1. How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors.
    Candi E; Agostini M; Melino G; Bernassola F
    Hum Mutat; 2014 Jun; 35(6):702-14. PubMed ID: 24488880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
    Venkatanarayan A; Raulji P; Norton W; Chakravarti D; Coarfa C; Su X; Sandur SK; Ramirez MS; Lee J; Kingsley CV; Sananikone EF; Rajapakshe K; Naff K; Parker-Thornburg J; Bankson JA; Tsai KY; Gunaratne PH; Flores ER
    Nature; 2015 Jan; 517(7536):626-30. PubMed ID: 25409149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.
    Costanzo A; Pediconi N; Narcisi A; Guerrieri F; Belloni L; Fausti F; Botti E; Levrero M
    FEBS Lett; 2014 Aug; 588(16):2590-9. PubMed ID: 24983500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 and p73, the ancestors of p53.
    Dötsch V; Bernassola F; Coutandin D; Candi E; Melino G
    Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004887. PubMed ID: 20484388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One, two, three--p53, p63, p73 and chemosensitivity.
    Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
    Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating the genome surveillance system: miRNAs and the p53 super family.
    Bailey SG; Sanchez-Elsner T; Stephanou A; Cragg MS; Townsend PA
    Apoptosis; 2010 May; 15(5):541-52. PubMed ID: 20091234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity.
    Marcel V; Petit I; Murray-Zmijewski F; Goullet de Rugy T; Fernandes K; Meuray V; Diot A; Lane DP; Aberdam D; Bourdon JC
    Cell Death Differ; 2012 May; 19(5):816-26. PubMed ID: 22075982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear.
    Monti P; Ghiorzo P; Menichini P; Foggetti G; Queirolo P; Izzotti A; Fronza G
    Oncol Rep; 2017 Oct; 38(4):1985-1994. PubMed ID: 28849221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development.
    Monti P; Ciribilli Y; Foggetti G; Menichini P; Bisio A; Cappato S; Inga A; Divizia MT; Lerone M; Bocciardi R; Fronza G
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31789342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p73 in apoptosis.
    Stiewe T; Pützer BM
    Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk among p53 family members in cutaneous carcinoma.
    Missero C; Antonini D
    Exp Dermatol; 2014 Mar; 23(3):143-6. PubMed ID: 24417641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p73 and p63: why do we still need them?
    Blandino G; Dobbelstein M
    Cell Cycle; 2004 Jul; 3(7):886-94. PubMed ID: 15254416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73.
    Venkatanarayan A; Raulji P; Norton W; Flores ER
    Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
    Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
    Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The coordinated interaction of multifunctional members of p53 family determines many key processes in multicellular organisms].
    Vilgelm AE; Zaika AI; Prasolov VS
    Mol Biol (Mosk); 2011; 45(1):180-97. PubMed ID: 21485507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the TP73 gene and its transcripts in neuro-oncology.
    Jancalek R
    Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.